BAKER BROS. ADVISORS LP Insider Trades

Insider Trading History

Track insider trading activity for BAKER BROS. ADVISORS LP. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Prelude Therapeutics
Prelude Therapeutics PRLD
10% owner
Holding Value $166k 38,000 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 38,000 shares
$3.94
$4.38
Incyte
Incyte INCY
10% owner
Holding Value $2.94B 28,205,360 shares
Last Trade
Jun 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$946k 9,395 shares
$100.64
$104.40
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $163M 2,744,894 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.35M 48,630 shares
$48.38
$59.49
Tscan Therapeutics
Tscan Therapeutics TCRX
Director
Holding Value $61.7k 67,000 shares
Last Trade
May 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66.3k 67,000 shares
$0.99
$0.92
Incyte
Incyte INCY
10% owner
Holding Value $2.94B 28,203,718 shares
Last Trade
May 08, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.48M 15,000 shares
$98.56
$104.40
Incyte
Incyte INCY
10% owner
Holding Value $296M 2,833,039 shares
Last Trade
May 08, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.48M 15,000 shares
$98.56
$104.40
Incyte
Incyte INCY
10% owner
Holding Value $0 0 shares
Last Trade
May 08, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.48M 15,000 shares
$98.56
$104.40
Prelude Therapeutics
Prelude Therapeutics PRLD
10% owner
Holding Value $88.1M 20,105,994 shares
Last Trade
Apr 21, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.88M 2,137,651 shares
$4.62
$4.38
Prelude Therapeutics
Prelude Therapeutics PRLD
10% owner
Holding Value $7.35M 1,678,273 shares
Last Trade
Apr 21, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$529k 114,601 shares
$4.62
$4.38
Replimune Group
Replimune Group REPL
10% owner
Holding Value $508k 44,500 shares
Last Trade
Apr 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$339k 44,500 shares
$7.61
$11.42
Incyte
Incyte INCY
10% owner
Holding Value $2.94B 28,188,718 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.6k 421 shares
$94.12
$104.40
Incyte
Incyte INCY
10% owner
Holding Value $294M 2,818,039 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.6k 421 shares
$94.12
$104.40
DBV Technologies
DBV Technologies DBVT
Director
Holding Value $0 0 shares
Last Trade
Jan 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$448M 25,005,240 shares
$17.93
$16.11
DBV Technologies
DBV Technologies DBVT
Director
Holding Value $403M 25,005,240 shares
Last Trade
Jan 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$448M 25,005,240 shares
$17.93
$16.11
DBV Technologies
DBV Technologies DBVT
Director
Holding Value $37M 2,299,656 shares
Last Trade
Jan 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$41.2M 2,299,656 shares
$17.93
$16.11
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc BCYC
10% owner
Holding Value $40.1M 10,018,674 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$127k 19,000 shares
$6.68
$4.00
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc BCYC
10% owner
Holding Value $3.75M 937,483 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$127k 19,000 shares
$6.68
$4.00
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc BCYC
10% owner
Holding Value $152k 38,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$269k 38,000 shares
$7.08
$4.00
Incyte
Incyte INCY
10% owner
Holding Value $2.94B 28,188,297 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.4k 328 shares
$98.77
$104.40
Incyte
Incyte INCY
10% owner
Holding Value $294M 2,817,618 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.4k 328 shares
$98.77
$104.40

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up